Ad

Opexa Therapeutics, Inc.
NASDAQ: OPXA
Precision Immunotherapy
July 2016
The Woodlands, TX
Precision Immunotherapy®

Ad

2
Forward-Looking Statements
All statements in this presentation other than those of historical fact, including statements...

Ad

3
Opexa Investment Highlights
 PIPELINE
• Tcelna®: Phase 2b for secondary progressive multiple sclerosis (SPMS), limited
...

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

Ad

1 of 23 Ad
1 of 23 Ad